Treatment with a Sirt1 Activator Resveratrol Prevents Cardiomyopathy in Dystrophin-Deficient Mice

被引：0
|
作者：
Kuno, Atsushi [1 ,2 ]
Hori, Yusuke [2 ]
Sato, Tatsuya [1 ]
Kouzu, Hidemichi [1 ]
Tanno, Masaya [1 ]
Miki, Takayuki [1 ]
Horio, Yoshiyuki [2 ]
Miura, Tetsuji [1 ]
机构：
[1] Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan
[2] Sapporo Med Univ, Dept Pharmacol, Sch Med, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2011年 / 17卷 / 09期
关键词：
D O I：
10.1016/j.cardfail.2011.06.480
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [1] Long-Term Treatment with the SIRT1 Activator Resveratrol Ameliorates Cardiomyopathy in Dystrophin-Deficient Mice
    Kuno, Atsushi
    Hori, Yusuke
    Tanno, Masaya
    Kouzu, Hidemichi
    Itoh, Takahito
    Sunaga, Daisuke
    Horio, Yoshiyuki
    Miura, Tetsuji
    [J]. CIRCULATION, 2011, 124 (21)
  • [2] Resveratrol, a SIRT1 activator, prevents cardiomyopathy in dystrophin-deficient mice by down-regulation of p300
    Kuno, A.
    Tanno, M.
    Miki, T.
    Ishikawa, S.
    Horio, Y.
    Miura, T.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 803 - 803
  • [3] Resveratrol ameliorates cardiomyopathy in dystrophin-deficient mice
    Kuno, Atsushi
    Hori, Yusuke
    Hosoda, Ryusuke
    Miura, Tetsuji
    Horio, Yoshiyuki
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 204P - 204P
  • [4] Resveratrol Improves Cardiomyopathy in Dystrophin-deficient Mice through SIRT1 Protein-mediated Modulation of p300 Protein
    Kuno, Atsushi
    Hori, Yusuke S.
    Hosoda, Ryusuke
    Tanno, Masaya
    Miura, Tetsuji
    Shimamoto, Kazuaki
    Horio, Yoshiyuki
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (08) : 5963 - 5972
  • [5] Dystrophin-Deficient Cardiomyopathy
    Kamdar, Forum
    Garry, Daniel J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (21) : 2533 - 2546
  • [6] Sirt1 Activator Resveratrol Ameliorates Pulmonary Fibrosis In Mice
    Mise, N.
    Fernandez, I. E.
    Eickelberg, O.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [7] Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin-Deficient Hearts
    Hammers, David W.
    Sleeper, Margaret M.
    Forbes, Sean C.
    Shima, Ai
    Walter, Glenn A.
    Sweeney, H. Lee
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (08):
  • [8] The SIRT1 Activator Resveratrol Prevents Fat-Induced β-Cell Dysfunction In Vivo
    Desai, Tejas
    Ivovic, Alex
    Hau, Bernard
    Koulajian, Khajag
    Breen, Danna
    Giacca, Adria
    [J]. DIABETES, 2012, 61 : A448 - A448
  • [9] The Sirt1 activator resveratrol improved hematopoiesis in pancytopenia mice induced by irradiation
    Song, Xu-Rui
    Cheng, Yan-Qiong
    Su, Ding-Feng
    Liu, Ai-Jun
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2019, 140 (01) : 79 - 85
  • [10] Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity
    Beher, Dirk
    Wu, John
    Cumine, Suzanne
    Kim, Ki Won
    Lu, Shu-Chen
    Atangan, Larissa
    Wang, Minghan
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 74 (06) : 619 - 624
12345